Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-20-008104

Corporate Executive VP & CFO sold 4,188 shares at an average $162.26 ($679,535)

  • Corporate Executive VP & CFO acquired 4,188 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Option exercise +4,188 $73.70 $308,656 24,663 D
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Sale −868 $160.45 $139,271 23,795 D
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Sale −898 $161.58 $145,095 22,897 D
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Sale −1,027 $162.27 $166,654 21,870 D
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Sale −657 $163.38 $107,339 21,213 D
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Sale −738 $164.19 $121,176 20,475 D
Derivatives
Smith David Ross Corporate Executive VP & CFO 2020-02-26 Option exercise · Stock Options (Right to Buy) −4,188 0 D
Open-market sales · 4,188 sh · avg $162.26 · $679,535
Loading xslF345X03/form4.xml…